Last reviewed · How we verify

NCT06242262

Deep Neuromuscular Block With Low Pressure Pneumoperitoneum in Laparoscopic Abdominal Surgeries

Completed NA Last updated 22 October 2024
What this trial tests

NA trial testing Deep neuromuscular block in Deep Neuromuscular Block in 44 participants. Completed in 1 March 2024.

Timeline
3 October 2023
Primary endpoint
1 March 2024
1 March 2024

Quick facts

Lead sponsorTanta University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment44
Start date3 October 2023
Primary completion1 March 2024
Estimated completion1 March 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 18 to 65, any sex, with Deep Neuromuscular Block or Low Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effect of deep neuromuscular block on postoperative pain, duration of surgery, quality of surgical field, length of recovery room stays, Total amount of rescue analgesic, postoperative nausea/vomiting, and length of hospital stay.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Deep Neuromuscular Block with Low Pressure Pneumoperitoneum in Laparoscopic Abdominal Surgeries: A Randomized Controlled Trial.
    Mohamed Ibrahim A, Said ElSharkawy M, Khalil Abdelrahman R, Elabd Hassan A, et al · · 2024 · PMID 40689105 · DOI 10.5812/aapm-150995

Verify or expand the search:

Other trials of Deep neuromuscular block

Trials testing the same drug.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06242262.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing